Early Placebo Improvement May Be a Marker for Long-Term Placebo Response in Schizophrenia Trials
Investigators examine patients who demonstrated improvement after placebo injections and aimed to determine criteria to predict subsequent response.
All articles by Emily Pond
Family History of Depression Associated With Worse Cognition in First-Degree Relatives
General impairment in cognition is a feature of first-degree relatives of family members with major depressive disorder.
Depression, Obesity Associated With Chronic Hip Pain
The association between chronic and disabling hip pain, and obesity and depression was examined.
Guanfacine Augmentation for Cognitive Therapy Effective for Schizotypal Personality Disorder
Augmentation with guanfacine alongside cognitive remediation and social skills may be an effective intervention for patients with schizotypal personality disorder.
Physical Activity May Be Protective Against Cognitive Decline in Older Adults With Depression
Participating in physical activity for 150 min/wk at moderate-to-vigorous intensity may protect older adults with symptoms of depression from cognitive decline.
High Religiosity, Polygenic Risk Score Influence Religious Delusions in Schizophrenia
Strong religious activity and high polygenic schizophrenia risk scores are independent risk factors for religious delusions in schizophrenia and schizoaffective disorder.
Benzodiazepines and Related Drugs Associated With Increased Pneumonia Risk
Current or recent exposure to benzodiazepines and related drugs may increase the risk for pneumonia.
Should Mental Health Screenings for Physicians Be Standard Procedure?
The suicide rate among physicians far exceeds that of the general population.
Combined Treatment With Naltrexone, Ketamine Effective for Depressive Symptoms
A combination of an opiate receptor antagonist with ketamine may reduce addiction risk in patients with depression.
Search Query Volumes Reflect the Effect of #MeToo
Internet searches on sexual assault and harassment have greatly increased since the start of the #MeToo campaign.
Next post in General Psychiatry
